Maria V. Sanchez-Martinez
Murcia, MU, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Emapalumab for the Treatment of Peri-Graft Hemophagocytic Lymphohistiocytosis Reactivation in a Patient With Familial Hemophagocytic Lymphohistiocytosis Type 3.
Journal: Pediatric blood & cancer
Published: June 03, 2026
HLA class-I genotyping to personalize Bacille Calmette-Guerin immunotherapy in bladder cancer.
Journal: Oncoimmunology
Published: December 12, 2025
Interplay of KIR2DL5, nitric oxide, and tobacco smoking in predisposition to bladder cancer.
Journal: Frontiers in cell and developmental biology
Published: May 20, 2025
Computational flow cytometry immunophenotyping at diagnosis is unable to predict relapse in childhood B-cell Acute Lymphoblastic Leukemia.
Journal: Computers in biology and medicine
Published: November 20, 2024
Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with M. bovis BCG or Other Therapies.
Journal: Biomedicines
Published: November 13, 2024
CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.
Journal: Journal of hematology & oncology
Published: November 05, 2024
HLA-A*03 may confer protection against long COVID through an enhanced immune response.
Journal: Infectious diseases now
Published: October 18, 2024
Exploring the Immunoresponse in Bladder Cancer Immunotherapy.
Journal: Cells
Published: September 30, 2024
HLA-C*07 is associated with symptomatic HIV-1-associated neurocognitive disorders (HAND) and immune dysregulation.
Journal: Infectious diseases (London, England)
Published: May 14, 2024
Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 20, 2023
Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 23, 2022
The shape of cancer relapse: Topological data analysis predicts recurrence in paediatric acute lymphoblastic leukaemia.
Journal: PLoS computational biology
Published: September 29, 2022
Last Updated: 09/26/2026